Offer - Urjas Oil for just ₹ 1 X
Isonit 30 Mg Tablet SR is a prescription drug, available for use as Tablet. Angina are some of its major therapeutic uses.
The optimal dosage of Isonit 30 Mg Tablet SR is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Isonit 30 Mg Tablet SR include Headache, Dizziness, Flushing. Besides the aforementioned side effects, there are other adverse effects of Isonit 30 Mg Tablet SR as well, which are listed below. These side effects of Isonit 30 Mg Tablet SR are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Isonit 30 Mg Tablet SR has a Mild effect for pregnant women and Mild effect on lactating mothers. In addition, Isonit 30 Mg Tablet SR's effects on the liver, heart and kidney are discussed below in the Isonit 30 Mg Tablet SR related warnings section.
Individuals suffering from medical conditions like Low Blood Pressure (Hypotension), Anemia must refrain from the use of Isonit 30 Mg Tablet SR since this can cause severe adverse effects. The section on Isonit 30 Mg Tablet SR contraindications lists all such conditions.
Drug interactions for Isonit 30 Mg Tablet SR have been reported in the medical literature. See below for a complete list.
You should also be aware that Isonit 30 Mg Tablet SR is not safe while driving, and is not addiction.
Isonit 30 Mg Tablet SR is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Isonit 30 Mg Tablet SR safe for pregnant women?
Isonit rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Isonit 30 Mg Tablet SR safe during breastfeeding?
Isonit may have very limited harmful effects for breastfeeding women.
What is the effect of Isonit 30 Mg Tablet SR on the Kidneys?
Using Isonit does not have any harmful effects on kidneys.
What is the effect of Isonit 30 Mg Tablet SR on the Liver?
Using Isonit does not have any harmful effects on the liver.
What is the effect of Isonit 30 Mg Tablet SR on the Heart?
Side effects of Isonit rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Isonit 30 Mg Tablet SR unless your doctor advises you to do so -
Is this Isonit 30 Mg Tablet SR habit forming or addictive?
Isonit 30 Mg Tablet SR does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Isonit 30 Mg Tablet SR. So it is best to avoid driving.
Is it safe?
Isonit 30 Mg Tablet SR should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Isonit 30 Mg Tablet SR cannot treat any kind of mental disorder.
Interaction between Food and Isonit 30 Mg Tablet SR
Information is not available on the interaction of any foods with Isonit 30 Mg Tablet SR, due to a lack of research on this.
Interaction between Alcohol and Isonit 30 Mg Tablet SR
It is difficult to say anything about the effect of Isonit 30 Mg Tablet SR and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; monoket® (isosorbide mononitrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 544
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 716-718